Depression drug study halted early: what happened?
NCT ID NCT04634669
First seen Jan 29, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study looked at the long-term safety and effectiveness of an experimental drug called AXS-05 for people with treatment-resistant depression (depression that hasn't improved with other treatments). The study enrolled 181 adults who either completed a prior AXS-05 study or currently had major depression with prior treatment failures. Participants took AXS-05 and were monitored for side effects. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Site
Little Rock, Arkansas, 72209, United States
-
Clinical Research Site
Redlands, California, 92374, United States
-
Clinical Research Site
Sherman Oaks, California, 91403, United States
-
Clinical Research Site
Upland, California, 91786, United States
-
Clinical Research Site
Miami, Florida, 33122, United States
-
Clinical Research Site
Miami Lakes, Florida, 33016, United States
-
Clinical Research Site
Orlando, Florida, 32081, United States
-
Clinical Research Site
Chicago, Illinois, 60634, United States
-
Clinical Research Site
Boston, Massachusetts, 02131, United States
-
Clinical Research Site
Berlin, New Jersey, 08009, United States
-
Clinical Research Site
Rochester, New York, 14618, United States
-
Clinical Research Site
Staten Island, New York, 10312, United States
-
Clinical Research Site
Hickory, North Carolina, 28601, United States
-
Clinical Research Site
Raleigh, North Carolina, 27609, United States
-
Clinical Research Site
Cincinnati, Ohio, 45215, United States
-
Clinical Research Site
Middleburg Heights, Ohio, 44130, United States
-
Clinical Research Site
Media, Pennsylvania, 19063, United States
-
Clinical Research Site
Dallas, Texas, 75243, United States
-
Clinical Research Site
Friendswood, Texas, 77546, United States
-
Clinical Research Site
Everett, Washington, 98201, United States
Conditions
Explore the condition pages connected to this study.